Pulse Biosciences (PLSE) Cost of Revenue (2021 - 2025)

Name: Pulse Biosciences (PLSE) Cost of Revenue (2021 - 2025) | Business Quant
Creator: Business Quant

Pulse Biosciences' quarterly Cost of Revenue came in at $279000.0 in Q3 2025, down 78.39% quarter-over-quarter from $1.3 million in Q4 2022.

Pulse Biosciences has reported Cost of Revenue for 3 years, with the latest figure at $279000.0 in Q3 2025.

For the quarter ending Q3 2025, Cost of Revenue changed N/A year-over-year to $279000.0; the trailing twelve-month figure through Sep 2025 stood at $279000.0 (changed N/A YoY), and the FY2022 full-year result was $11.9 million, up 506.91% from the prior year.
Cost of Revenue for Q3 2025 stood at $279000.0, down from $1.3 million in the prior quarter.
The five-year high for Cost of Revenue was $8.4 million in Q3 2022, with the low at $279000.0 in Q3 2025.
Average Cost of Revenue over 3 years is $2.0 million, with a median of $1.2 million recorded in 2021.
Peak annual rise in Cost of Revenue reached 1055.43% in 2022, while the deepest fall reached 4.03% in 2022.
Tracing PLSE's Cost of Revenue over 3 years: stood at $1.2 million in 2021, then climbed by 4.03% to $1.3 million in 2022, then sank by 78.39% to $279000.0 in 2025.
The last three Cost of Revenue figures came in at $279000.0 (Q3 2025), $1.3 million (Q4 2022), and $8.4 million (Q3 2022), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	940.30 Mn
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	2.56 Bn
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	540.43 Mn
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	548.50 Mn
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	64.00 Mn
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	328.90 Mn
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	303.50 Mn
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	1.81 Bn
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	630.96 Mn
10	Pulse Biosciences	1.72 Bn	1.72 Bn	-	-

Download Data 🔒